Department of Dermatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing China.
Graduate College, Beijing University of Chinese Medicine, Beijing, China.
J Dermatolog Treat. 2022 Mar;33(2):671-681. doi: 10.1080/09546634.2020.1789048. Epub 2020 Jul 9.
Psoriasis vulgaris (PV) not only affects patients' skin health but also increases the risk of coronary heart disease and diabetes, which brings both physical and mental harms. Its pathogenesis is complex, and the multitarget effect of traditional Chinese medicine (TCM) is especially advantageous. Because a considerable number of randomized controlled trials related to TCM exhibit design defects, small sample size, or inadequate intervention time, so the status of TCM in the treatment of PV cannot be fully clarified. We reviewed the controlled clinical trials published over the past decade and selected 17 high-quality articles from over 2000 papers. The results suggest that TCM might be beneficial for decrease in PASI scores, thus, TCM might be an effective alternative therapy for PV management. The safety of TCM on PV was also assessed in our analysis. The more strictly designed and long-term observations of TCM for PV are supposed to be conducted in the future.
寻常型银屑病(PV)不仅影响患者的皮肤健康,而且增加患冠心病和糖尿病的风险,给患者带来身心双重伤害。其发病机制复杂,中医药的多靶点作用尤其具有优势。由于相当数量的中医药相关随机对照试验存在设计缺陷、样本量小或干预时间不足,因此无法充分阐明中医药在 PV 治疗中的地位。我们对过去十年发表的对照临床试验进行了综述,从 2000 多篇论文中筛选出 17 篇高质量文章。结果表明,中医药可能有助于降低 PASI 评分,因此,中医药可能是 PV 管理的一种有效替代疗法。我们的分析还评估了中医药治疗 PV 的安全性。未来应该进行更严格设计和长期观察中医药治疗 PV 的疗效。